CN1525861A - 用于治疗眼压过高和青光眼的方法 - Google Patents

用于治疗眼压过高和青光眼的方法 Download PDF

Info

Publication number
CN1525861A
CN1525861A CNA028137566A CN02813756A CN1525861A CN 1525861 A CN1525861 A CN 1525861A CN A028137566 A CNA028137566 A CN A028137566A CN 02813756 A CN02813756 A CN 02813756A CN 1525861 A CN1525861 A CN 1525861A
Authority
CN
China
Prior art keywords
group
ketone group
prostaglandin
prostaglandin compound
rudimentary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028137566A
Other languages
English (en)
Chinese (zh)
Inventor
��Ұ¡˾
上野隆司
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Sucampo GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo GmbH filed Critical Sucampo GmbH
Publication of CN1525861A publication Critical patent/CN1525861A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA028137566A 2001-05-14 2002-05-13 用于治疗眼压过高和青光眼的方法 Pending CN1525861A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29035501P 2001-05-14 2001-05-14
US60/290,355 2001-05-14

Publications (1)

Publication Number Publication Date
CN1525861A true CN1525861A (zh) 2004-09-01

Family

ID=23115609

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028137566A Pending CN1525861A (zh) 2001-05-14 2002-05-13 用于治疗眼压过高和青光眼的方法

Country Status (10)

Country Link
US (1) US20050014837A1 (enExample)
EP (1) EP1390035A1 (enExample)
JP (1) JP2004529177A (enExample)
KR (1) KR20040008174A (enExample)
CN (1) CN1525861A (enExample)
BR (1) BR0209601A (enExample)
CA (1) CA2444627A1 (enExample)
MX (1) MXPA03010363A (enExample)
NO (1) NO20035043D0 (enExample)
WO (1) WO2002092098A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003215820A1 (en) * 2002-03-28 2003-10-13 Sucampo Ag Method for treating ocular hypertension and glaucoma
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
KR20120005052A (ko) * 2003-08-21 2012-01-13 수캄포 아게 안과용 조성물
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
DK2598118T3 (en) * 2010-07-29 2018-12-10 Allergan Inc CONSERVATIVE-FREE BIMATOPROST AND TIMOLOL SOLUTIONS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
ES2067864T3 (es) * 1990-05-22 1995-04-01 R Tech Ueno Ltd Tratamiento de la hipertension ocular con una combinacion sinergica para administracion ocular.
DK0561073T3 (da) * 1992-03-19 2001-11-12 R Tech Ueno Ltd Behandling af øjenhypertension
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
DE69829227D1 (de) * 1998-12-25 2005-04-07 Sucampo A G Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom
US6458836B1 (en) * 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma

Also Published As

Publication number Publication date
KR20040008174A (ko) 2004-01-28
WO2002092098A1 (en) 2002-11-21
NO20035043D0 (no) 2003-11-13
CA2444627A1 (en) 2002-11-21
JP2004529177A (ja) 2004-09-24
EP1390035A1 (en) 2004-02-25
MXPA03010363A (es) 2004-03-16
BR0209601A (pt) 2004-03-23
US20050014837A1 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
CN1399548A (zh) 用于治疗外分泌障碍的组合物
CN1106844C (zh) 前列腺烷酸化合物治疗视神经障碍
US5252605A (en) Promotion of wound-healing with 15-keto-prostaglandin compounds
CN1522147A (zh) 含有15-酮基-前列腺素类化合物的用于治疗药物诱导的便秘的组合物
CN1206997C (zh) 内皮缩血管肽拮抗剂
CN1525861A (zh) 用于治疗眼压过高和青光眼的方法
EP0455448A2 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
CN1273140C (zh) 导泻组合物
CN1241570C (zh) 胆汁分泌促进组合物
CN1126545C (zh) 眼科用制剂
US8889735B2 (en) Method for treating asthenopia
EP0458590B1 (en) Treatment of ocular hypertention with a synergistic combination
TWI403324B (zh) 醫藥組成物
EP0458587B1 (en) Synergistic combination for ophthalmic use
CN1646134A (zh) 用于治疗眼压过高和青光眼的方法和组合物
EP0501678B1 (en) Treatment of ocular hypertension with a synergistic combination
CN1575178A (zh) 治疗眼压过高和青光眼的方法和组合物
CN1127342C (zh) 降低眼压的药物
CN1246797A (zh) 门静脉高血压抑制剂
CN1429112A (zh) 用于治疗眼压过高和青光眼的组合物
US5234954A (en) Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
RU2481841C2 (ru) Способ и композиция для лечения заболеваний периферических сосудов
AU2002255346A1 (en) Method for treatingocular hypertension and glaucoma
JP2005519978A (ja) 高眼圧症および緑内障の処置方法
HK1181675A (en) Pharmaceutical composition for treating macular edema

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication